AEI vs RARE · rev $2.0M vs rev $350.0M
Alset Ehome International Inc (AEI) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Alset Ehome International Inc (AEI) is a real estate - development company listed on NASDAQ.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported AEI revenue for 2026-06-30 was $2.0M. Net income was -$9.8M. AEI currently screens at market cap $53.3M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
AEI currently screens at market cap $53.3M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the AEI and RARE stock pages for the full models.
Not investment advice.